{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:55:40Z","timestamp":1790812540571,"version":"4.1.0"},"reference-count":50,"publisher":"Georg Thieme Verlag KG","issue":"CP","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Thrombosis Research Center","award":["SKGJ-MED-012"],"award-info":[{"award-number":["SKGJ-MED-012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TH Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background Patients with incident venous thromboembolism (VTE) have a high risk of recurrence. Recent studies have shown that plasma levels of human epididymis protein 4 (HE4) are associated with increased risk of future incident VTE.<\/jats:p>\n                  <jats:p>Objective To investigate whether plasma HE4 levels are associated with risk of recurrent VTE.<\/jats:p>\n                  <jats:p>Methods Patients with first-lifetime VTE (n = 896) derived from the Tr\u00f8ndelag Health Study (HUNT3; 2006\u20132019) were followed from the VTE date. Symptomatic and objectively confirmed VTE recurrences were recorded during the study period. Plasma HE4 levels were measured by Somascan at the time of inclusion in the source cohort (HUNT3, prior to incident VTE). Cox regression models were used to estimate hazard ratios (HRs) for VTE recurrence across quartiles of plasma HE4 levels adjusted for age, sex, and body mass index. Subgroup analyses by type of incident VTE were also performed.<\/jats:p>\n                  <jats:p>Results During follow-up, 116 patients developed recurrent VTE. We found no significant association between quartiles of plasma HE4 levels and absolute or relative risk of recurrent VTE. The HR for recurrence in individuals with elevated plasma HE4 levels (Q4) versus low HE4 levels (Q1) was HR: 0.82 (95% confidence interval [CI]: 0.46\u20131.49). Similarly, no association was found between plasma HE4 levels and recurrent VTE in any subgroup analyses (index deep vein thrombosis, pulmonary embolism, provoked VTE, or unprovoked VTE).<\/jats:p>\n                  <jats:p>Conclusion Our results suggest that inherent plasma HE4 levels are not useful as a risk biomarker for recurrent VTE.<\/jats:p>","DOI":"10.1055\/a-2961-2256","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:54:58Z","timestamp":1790031298000},"source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Plasma Level of Human Epididymis Protein 4 and Risk of Recurrence after First Venous Thromboembolism: The HUNT Study"],"prefix":"10.1055","volume":"10","author":[{"given":"Celina J.","family":"Cathro","sequence":"additional","affiliation":[{"name":"Thrombosis Research Group (TREC), UiT The Arctic University of Norway, Troms, Norway","place":["Troms\u00f8"],"department":["Department of Clinical Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-9696","authenticated-orcid":false,"given":"Sigrid K.","family":"Br\u00e6kkan","sequence":"additional","affiliation":[{"name":"Thrombosis Research Group (TREC), UiT The Arctic University of Norway, Troms, Norway","place":["Troms\u00f8"],"department":["Department of Clinical Medicine"]},{"name":"Thrombosis Research Center (TREC), University Hospital of North Norway, Troms, Norway","place":["Troms\u00f8"],"department":["Division of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Hveem","sequence":"additional","affiliation":[{"name":"HUNT Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology, Tr\u00f8ndelag, Norway","place":["Trondheim"],"department":["Department of Public Health and Nursing"]},{"name":"HUNT Research Center, Norwegian University of Science and Technology, Tr\u00f8ndelag, Norway","place":["Trondheim"]},{"name":"St Olav\u2019s Hospital HF, Tr\u00f8ndelag, Norway","place":["Trondheim"],"department":["Department of Research"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Bjarne","family":"Hansen","sequence":"additional","affiliation":[{"name":"Thrombosis Research Group (TREC), UiT The Arctic University of Norway, Troms, Norway","place":["Troms\u00f8"],"department":["Department of Clinical Medicine"]},{"name":"Thrombosis Research Center (TREC), University Hospital of North Norway, Troms, Norway","place":["Troms\u00f8"],"department":["Division of Internal Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"F Khan","year":"2021","journal-title":"Lancet"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","article-title":"Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death","volume":"37","author":"C AL Arnesen","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"S R Kahn","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: a new concept for chronic complications of pulmonary embolism","volume":"28","author":"F A Klok","year":"2014","journal-title":"Blood Rev"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jth.13587","article-title":"Recurrence and mortality after first venous thromboembolism in a large population-based cohort","volume":"15","author":"N Arshad","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1538-7836.2006.01795.x","article-title":"Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months","volume":"4","author":"S Schulman","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jtha.2022.12.006","article-title":"Venous thromboembolism and risk of depression: a\u2009population-based cohort study","volume":"21","author":"H J\u00f8rgensen","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"e1003770","DOI":"10.1371\/journal.pmed.1003770","article-title":"Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: a population-based cohort study","volume":"18","author":"H J\u00f8rgensen","year":"2021","journal-title":"PLoS Med"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2146\/ajhp140204","article-title":"Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective","volume":"72","author":"J P Casciano","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"19","key":"ref10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199205073261902","article-title":"The clinical course of pulmonary embolism","volume":"326","author":"J L Carson","year":"1992","journal-title":"N Engl J Med"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"V Pengo","year":"2004","journal-title":"N Engl J Med"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"P Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3324\/haematol.2014.112896","article-title":"Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism","volume":"100","author":"T van der Hulle","year":"2015","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2019.06.032","article-title":"The association of recurrence and bleeding events with mortality after venous thromboembolism: from the COMMAND VTE registry","volume":"292","author":"Y Yamashita","year":"2019","journal-title":"Int J Cardiol"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/jcm9051582","article-title":"Predicting the risk of recurrent venous thromboembolism: current challenges and future opportunities","volume":"9","author":"H Stevens","year":"2020","journal-title":"J Clin Med"},{"key":"ref16","first-page":"451","article-title":"Assessing the risk of recurrent venous thromboembolism\u2013a practical approach","volume":"11","author":"J Fahrni","year":"2015","journal-title":"Vasc Health Risk Manag"},{"issue":"19","key":"ref17","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"T L Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"01","key":"ref18","first-page":"64","article-title":"Individualized risk assessments for recurrent venous thromboembolism: new frontiers in the era of direct anticoagulants","volume":"2","author":"J Wang","year":"2021","journal-title":"Hematology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"M A de Winter","year":"2021","journal-title":"Thromb Res"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"ESC Scientific Document Group. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"S V Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1519869","DOI":"10.3389\/fphar.2024.1519869","article-title":"Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials","volume":"15","author":"W Fu","year":"2025","journal-title":"Front Pharmacol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"K Iwahori","year":"2012","journal-title":"Tumour Biol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/ijc.IJC_752_19","article-title":"A clinical study of serum human epididymis protein 4 (HE4) in the diagnosis of pancreatic cancer","volume":"59","author":"W Liu","year":"2022","journal-title":"Indian J Cancer"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.30699\/ijp.2021.135323.2482","article-title":"HE4, a new potential tumor marker for early diagnosis and predicting of breast cancer progression","volume":"16","author":"N Mirmohseni Namini","year":"2021","journal-title":"Iran J Pathol"},{"issue":"13","key":"ref26","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"I Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"issue":"10","key":"ref27","first-page":"e30457","article-title":"The diagnostic accuracy of serum and urine human epididymis protein 4 (HE4) in ovarian cancer in 15,394 subjects: an updated meta-analysis","volume":"14","author":"N Nalini","year":"2022","journal-title":"Cureus"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchf.2012.11.005","article-title":"The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure","volume":"1","author":"R A de Boer","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00380-020-01744-4","article-title":"Serum human epididymis protein 4 levels in the prediction of the recurrence of atrial fibrillation after catheter ablation","volume":"36","author":"Z J Mao","year":"2021","journal-title":"Heart Vessel"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12931-022-02040-7","article-title":"Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease","volume":"23","author":"Y Zhan","year":"2022","journal-title":"Respir Res"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/labmed\/lmaa076","article-title":"The association between serum human epididymis protein 4 level and cardiovascular events in patients with chronic obstructive pulmonary disease","volume":"52","author":"H Lin","year":"2021","journal-title":"Lab Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"B Nagy Jr","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e16089","DOI":"10.7717\/peerj.16089","article-title":"A nomogram model for predicting lower extremity deep vein thrombosis after gynecologic laparoscopic surgery: a retrospective cohort study","volume":"11","author":"Y Zhao","year":"2023","journal-title":"PeerJ"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jtha.2026.03.009","article-title":"Plasma level of human epididymis protein 4 is associated with risk of future venous thromboembolism-the Tr\u00f8ndelag health study","volume":"24","author":"C J Cathro","year":"2026","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1093\/ije\/dyac095","article-title":"Cohort profile update: the HUNT study, Norway","volume":"52","author":"B O \u00c5svold","year":"2023","journal-title":"Int J Epidemiol"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ije\/dys095","article-title":"Cohort profile: the HUNT study, Norway","volume":"42","author":"S Krokstad","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"dyae073","DOI":"10.1093\/ije\/dyae073","article-title":"Data resource profile: the HUNT biobank","volume":"53","author":"M N\u00e6ss","year":"2024","journal-title":"Int J Epidemiol"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"L Gold","year":"2010","journal-title":"PLoS One"},{"issue":"07","key":"ref41","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/bloodadvances.2024015371","article-title":"Duration of primary\/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"9","author":"A Li","year":"2025","journal-title":"Blood Adv"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1055\/a-2484-0836","article-title":"The plasma proteome and risk of future venous thromboembolism-results from the HUNT study","volume":"125","author":"S K Br\u00e6kkan","year":"2025","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCULATIONAHA.125.074493","article-title":"Novel plasma proteomic markers and risk of venous thromboembolism","volume":"153","author":"W Tang","year":"2026","journal-title":"Circulation"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.2011.163","article-title":"Index event bias as an explanation for the paradoxes of recurrence risk research","volume":"305","author":"I J Dahabreh","year":"2011","journal-title":"JAMA"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/EDE.0000000000000131","article-title":"A nearly unavoidable mechanism for collider bias with index-event studies","volume":"25","author":"W D Flanders","year":"2014","journal-title":"Epidemiology"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review","volume":"166","author":"W K Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jth.12263","article-title":"Venous thrombosis: understanding the paradoxes of recurrence","volume":"11","author":"S C Cannegieter","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"N Bolstad","year":"2012","journal-title":"Tumour Biol"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review","volume":"66","author":"S Ferraro","year":"2013","journal-title":"J Clin Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"755268","DOI":"10.3389\/fmed.2021.755268","article-title":"Serum human epididymis protein 4 as a novel biomarker in identifying patients with interstitial lung disease in rheumatoid arthritis","volume":"8","author":"L Liang","year":"2021","journal-title":"Front Med"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","author":"R Clarke","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1515\/cclm-2022-0966","article-title":"Biological variation of CA 15-3, CA 125 and HE 4 on lithium heparinate plasma in apparently healthy Caucasian volunteers","volume":"61","author":"L Guillaume","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"17147","DOI":"10.1038\/s41598-022-22116-0","article-title":"Assessment of variability in the plasma 7k SomaScan proteomics assay","volume":"12","author":"J Candia","year":"2022","journal-title":"Sci Rep"}],"container-title":["TH Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2961-2256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:12:03Z","timestamp":1790809923000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2961-2256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":50,"journal-issue":{"issue":"CP","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026]]}},"alternative-id":["a29612256"],"URL":"https:\/\/doi.org\/10.1055\/a-2961-2256","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2512-9465"],"issn-type":[{"value":"2512-9465","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,21]]},"published":{"date-parts":[[2026,9,21]]}}}